Randomized withdrawal from nifedipine: Placebo-controlled study in patients with coronary artery spasm

Edgar C. Schick, Chang seng Liang, Frederick A. Heupler, Frederick R. Kahl, Kenneth M. Kent, Nicholas Z. Kerin, R. Roe Noble, Melvyn Rubenfire, Bernard Tabatznik, Richard W. Terry

Research output: Contribution to journalArticle

Abstract

A multicenter randomized double-blind withdrawal study was conducted to compare the efficacy of nifedipine to that of placebo in vasospastic angina. Following a 2-week single-blind nifedipine baseline period, during which nifedipine was maintained at prestudy levels, 38 patients, 19 taking placebo and 19 continuing nifedipine therapy, either completed a 4-week randomized phase or were prematurely withdrawn because of therapeutic failure. During the randomized phase, an increase in median anginal frequency (2.8 attacks/wk, p <0.003) and nitroglycerin usage (0.5 tablets/wk, p <0.03) occurred only in the placebo group. The randomized phase was prematurely terminated because of anginal exacerbation in 7 of 19 placebo patients (37%) (only 1 patient receiving nifedipine [p = 0.02] experienced anginal exacerbation). Double-blind therapy was judged effective in 16 patients (84%) receiving nifedipine and in 3 patients (16%) receiving placebo (p <0.001). Nifedipine was well tolerated. This study establishes the efficacy of nifedipine in the treatment of variant angina and validates previous clinical experience.

Original languageEnglish (US)
Pages (from-to)690-697
Number of pages8
JournalAmerican Heart Journal
Volume104
Issue number3
DOIs
StatePublished - 1982
Externally publishedYes

Fingerprint

Spasm
Nifedipine
Coronary Vessels
Placebos
Nitroglycerin
Therapeutics
Double-Blind Method
Tablets

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Schick, E. C., Liang, C. S., Heupler, F. A., Kahl, F. R., Kent, K. M., Kerin, N. Z., ... Terry, R. W. (1982). Randomized withdrawal from nifedipine: Placebo-controlled study in patients with coronary artery spasm. American Heart Journal, 104(3), 690-697. https://doi.org/10.1016/0002-8703(82)90257-5

Randomized withdrawal from nifedipine : Placebo-controlled study in patients with coronary artery spasm. / Schick, Edgar C.; Liang, Chang seng; Heupler, Frederick A.; Kahl, Frederick R.; Kent, Kenneth M.; Kerin, Nicholas Z.; Noble, R. Roe; Rubenfire, Melvyn; Tabatznik, Bernard; Terry, Richard W.

In: American Heart Journal, Vol. 104, No. 3, 1982, p. 690-697.

Research output: Contribution to journalArticle

Schick, EC, Liang, CS, Heupler, FA, Kahl, FR, Kent, KM, Kerin, NZ, Noble, RR, Rubenfire, M, Tabatznik, B & Terry, RW 1982, 'Randomized withdrawal from nifedipine: Placebo-controlled study in patients with coronary artery spasm', American Heart Journal, vol. 104, no. 3, pp. 690-697. https://doi.org/10.1016/0002-8703(82)90257-5
Schick, Edgar C. ; Liang, Chang seng ; Heupler, Frederick A. ; Kahl, Frederick R. ; Kent, Kenneth M. ; Kerin, Nicholas Z. ; Noble, R. Roe ; Rubenfire, Melvyn ; Tabatznik, Bernard ; Terry, Richard W. / Randomized withdrawal from nifedipine : Placebo-controlled study in patients with coronary artery spasm. In: American Heart Journal. 1982 ; Vol. 104, No. 3. pp. 690-697.
@article{e1d1ed1bab7246afa306ec1329227c49,
title = "Randomized withdrawal from nifedipine: Placebo-controlled study in patients with coronary artery spasm",
abstract = "A multicenter randomized double-blind withdrawal study was conducted to compare the efficacy of nifedipine to that of placebo in vasospastic angina. Following a 2-week single-blind nifedipine baseline period, during which nifedipine was maintained at prestudy levels, 38 patients, 19 taking placebo and 19 continuing nifedipine therapy, either completed a 4-week randomized phase or were prematurely withdrawn because of therapeutic failure. During the randomized phase, an increase in median anginal frequency (2.8 attacks/wk, p <0.003) and nitroglycerin usage (0.5 tablets/wk, p <0.03) occurred only in the placebo group. The randomized phase was prematurely terminated because of anginal exacerbation in 7 of 19 placebo patients (37{\%}) (only 1 patient receiving nifedipine [p = 0.02] experienced anginal exacerbation). Double-blind therapy was judged effective in 16 patients (84{\%}) receiving nifedipine and in 3 patients (16{\%}) receiving placebo (p <0.001). Nifedipine was well tolerated. This study establishes the efficacy of nifedipine in the treatment of variant angina and validates previous clinical experience.",
author = "Schick, {Edgar C.} and Liang, {Chang seng} and Heupler, {Frederick A.} and Kahl, {Frederick R.} and Kent, {Kenneth M.} and Kerin, {Nicholas Z.} and Noble, {R. Roe} and Melvyn Rubenfire and Bernard Tabatznik and Terry, {Richard W.}",
year = "1982",
doi = "10.1016/0002-8703(82)90257-5",
language = "English (US)",
volume = "104",
pages = "690--697",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Randomized withdrawal from nifedipine

T2 - Placebo-controlled study in patients with coronary artery spasm

AU - Schick, Edgar C.

AU - Liang, Chang seng

AU - Heupler, Frederick A.

AU - Kahl, Frederick R.

AU - Kent, Kenneth M.

AU - Kerin, Nicholas Z.

AU - Noble, R. Roe

AU - Rubenfire, Melvyn

AU - Tabatznik, Bernard

AU - Terry, Richard W.

PY - 1982

Y1 - 1982

N2 - A multicenter randomized double-blind withdrawal study was conducted to compare the efficacy of nifedipine to that of placebo in vasospastic angina. Following a 2-week single-blind nifedipine baseline period, during which nifedipine was maintained at prestudy levels, 38 patients, 19 taking placebo and 19 continuing nifedipine therapy, either completed a 4-week randomized phase or were prematurely withdrawn because of therapeutic failure. During the randomized phase, an increase in median anginal frequency (2.8 attacks/wk, p <0.003) and nitroglycerin usage (0.5 tablets/wk, p <0.03) occurred only in the placebo group. The randomized phase was prematurely terminated because of anginal exacerbation in 7 of 19 placebo patients (37%) (only 1 patient receiving nifedipine [p = 0.02] experienced anginal exacerbation). Double-blind therapy was judged effective in 16 patients (84%) receiving nifedipine and in 3 patients (16%) receiving placebo (p <0.001). Nifedipine was well tolerated. This study establishes the efficacy of nifedipine in the treatment of variant angina and validates previous clinical experience.

AB - A multicenter randomized double-blind withdrawal study was conducted to compare the efficacy of nifedipine to that of placebo in vasospastic angina. Following a 2-week single-blind nifedipine baseline period, during which nifedipine was maintained at prestudy levels, 38 patients, 19 taking placebo and 19 continuing nifedipine therapy, either completed a 4-week randomized phase or were prematurely withdrawn because of therapeutic failure. During the randomized phase, an increase in median anginal frequency (2.8 attacks/wk, p <0.003) and nitroglycerin usage (0.5 tablets/wk, p <0.03) occurred only in the placebo group. The randomized phase was prematurely terminated because of anginal exacerbation in 7 of 19 placebo patients (37%) (only 1 patient receiving nifedipine [p = 0.02] experienced anginal exacerbation). Double-blind therapy was judged effective in 16 patients (84%) receiving nifedipine and in 3 patients (16%) receiving placebo (p <0.001). Nifedipine was well tolerated. This study establishes the efficacy of nifedipine in the treatment of variant angina and validates previous clinical experience.

UR - http://www.scopus.com/inward/record.url?scp=0020449877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020449877&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(82)90257-5

DO - 10.1016/0002-8703(82)90257-5

M3 - Article

C2 - 6810682

AN - SCOPUS:0020449877

VL - 104

SP - 690

EP - 697

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 3

ER -